Somalogic, Inc.
2945 Wilderness Place
Boulder
Colorado
80301
United States
Tel: 303-625-9000
Website: http://www.somalogic.com/
Email: information@somalogic.com
About Somalogic, Inc.
SomaLogic was founded in 2000 by Larry Gold , with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed.
Building on the previous decade of aptamer research, SomaLogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences.
Our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare.
46 articles with Somalogic, Inc.
-
With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened this year. And there are many!
-
SomaLogic Reports Third Quarter 2021 Financial Results
11/15/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended September 30, 2021.
-
SomaLogic to Present at the Stifel 2021 Virtual Healthcare Conference
11/3/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Stifel 2021 Virtual Healthcare Conference.
-
SomaLogic to Announce Third Quarter 2021 Financial Results
10/28/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the third quarter 2021 before the market opens on Monday, November 15, 2021
-
SomaLogic Announces Upcoming Conference Participation and Analyst Meeting
9/22/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today is announcing upcoming conference participation in addition to its analyst meeting.
-
SomaLogic Announces Registration Statement Declared Effective and Reports 176% Y/Y Second Quarter and 187% First Half of 2021 Revenue Growth
8/16/2021
CM Life Sciences II today announced that the registration statement for their business combination has been declared effective by the US Securities Exchange Commission (“SEC” )
-
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
6/29/2021
Ixaka Ltd and SomaLogic announce a research collaboration to support the development of aptamer-based bispecific therapeutics.
-
Three partnerships were signed today between biopharmaceutical and therapeutics companies in a bid to develop treatment for major diseases with high mortality rates.
-
Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays
4/30/2019
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development
-
BioSpace Movers and Shakers: April 26
4/26/2019
Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more. -
SomaLogic announces new collaboration with Janssen Research & Development
4/11/2019
Companies to share proteomic and clinical data to drive new drug discovery and development, and precision health management
-
SomaLogic to Present at 37th Annual J. P. Morgan Healthcare Conference
1/2/2019
Dr. Smythe's presentation, which is included in the Conference's "Emerging Markets Track," is scheduled for Wednesday, January 9, 2019 at 3:00 p.m. Pacific Time.
-
deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples
12/13/2018
Largest-ever Protein Measurement Study Enhances deCODE's Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics
-
SomaLogic Licenses GNS Healthcare's REFS™ technology for analysis of its SOMAscan®-derived proteomic data
7/17/2018
Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets
-
Melody Harris, J.D., appointed Chief Legal Officer of SomaLogic
4/2/2018
SomaLogic announced today that Melody Harris has joined SomaLogic as the company's Chief Legal Officer.
-
SomaLogic Teams with Leeds Centre for Personalised Medicine and Health to Deliver SOMAscan Platform in Clinical Healthcare
2/6/2018
This collaboration - the first of its kind - aims to help individuals and professionals enhance health decisions by providing:
-
The successful round will accelerate SomaLogic's goal of becoming the world's leading provider of precision digital health insights.
-
SomaLogic Names a New CEO
4/5/2017
-
SomaLogic Announces That It Has Joined The iCarbonX Digital Life Alliance
1/5/2017
-
SomaLogic Raises Up to $60.5 Million From Visium Healthcare Partners to Support Strategic Growth Initiatives
3/1/2016